Electronic cigarettes: patterns of use, health effects, use in smoking cessation and regulatory issues

Tobacco Induced Diseases

Linda Worrall-Carter³  Andrew Wilson³  Nicholas Hann¹  Muhammad Aziz Rahman² 

[1] The University of Melbourne, Melbourne, Australia;The Cardiovascular Research Centre (CvRC), Australian Catholic University, Melbourne, Australia;St Vincent’s Hospital, Melbourne, Australia

关键词: Tobacco;    Smoking cessation;    Smoking;    Electronic cigarettes;    E-cigarettes;   

Others  :  1130868
DOI  :  10.1186/1617-9625-12-21

 received in 2014-04-01, accepted in 2014-10-27,  发布年份 2014

【 摘 要 】

Background

Electronic cigarettes (e-cigarettes) are battery-powered devices that vaporize a liquid solution to deliver a dose of inhaled nicotine to the user. There is ongoing debate regarding their regulation.

Objectives

This comprehensive narrative review aimed to discuss key issues including usage patterns, health effects, efficacy in smoking cessation and regulatory concerns with a view to informing future regulation and research agendas.

Methods

PubMed, Scopus and Web of Science databases were searched using the terms (electronic cigarettes OR e-cigarettes) for articles in English, relevant to humans and published during January 2009-January 2014.

Results

The literature search revealed 37 relevant articles. Findings suggest that e-cigarettes are mostly used by middle-aged current smokers, particularly males, to help them for quitting or for recreation. E-cigarettes contain very low levels of multiple toxic substances such as formaldehyde and acrolein, but these levels are many times lower than those found in cigarettes. They were found to have effectiveness in aiding smoking cessation to a limited degree. Debate continues regarding regulating their use for cessation versus heavy restrictions to control recreational use on the basis that it perpetuates nicotine addiction.

Conclusions

The cytotoxicity and long term health effects of e-cigarettes are unknown. Nevertheless the e-cigarette market continues to expand, largely driven by middle-aged smokers who claim to be using e-cigarettes in an attempt to reduce or quit smoking. E-cigarettes may have some potential as smoking cessation aids and, in the researchers’ view, should therefore be subject to further research and regulation similar to other nicotine replacement therapies.

【 授权许可】

   
2014 Rahman et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Foulds J, Veldheer S, Berg A: Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract 2011, 65(10):1037-1042.
• [2]Riker CA, Lee K, Darville A, Hahn EJ: E-cigarettes: promise or peril? Nurs Clin North Am 2012, 47(1):159-171.
• [3]Dawkins L, Turner J, Roberts A, Soar K: ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction 2013, 108(6):1115-1125.
• [4]Romagna G, Allifranchini E, Bocchietto E, Todeschi S, Esposito M, Farsalinos KE: Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 2013, 25(6):354-361.
• [5]Noel JK, Rees VW, Connolly GN: Electronic cigarettes: a new ‘tobacco’ industry? Tob Control 2011, 20(1):81.
• [6]Bialous SA, Sarma L: Electronic cigarettes and smoking cessation: a quandary? Lancet 2014, 383(9915):407-408.
• [7]Varkey B: Electronic cigarettes: the good, the bad and the unknown. Curr Opin Pulm Med 2014, 20(2):125-126.
• [8]Etter JF: Should electronic cigarettes be as freely available as tobacco? Yes. BMJ 2013, 346:f3845.
• [9]Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N: Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013, 382(9905):1629-1637.
• [10]Chapman S: Should electronic cigarettes be as freely available as tobacco cigarettes? No. BMJ 2013, 346:F3840.
• [11]Etter JF: Commentary on Goniewicz et al. (2014): if wisely regulated, electronic cigarettes can make cigarettes obsolete. Addiction 2014, 109(3):508-509.
• [12]Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P III, Benowitz N: Levels of selected carcinogens and toxicants in vapor from electronic cigarettes. Tob Control 2014, 23(2):133-139.
• [13]McAuley TR, Hopke PK, Zhao J, Babaian S: Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 2012, 24(12):850-857.
• [14]Schivo M, Avdalovic MV, Murin S: Non-cigarette tobacco and the lung. Clin Rev Allergy Immunol 2014, 46(1):34-53.
• [15]Cobb NK, Abrams DB: E-cigarette or drug-delivery device? Regulating novel nicotine products. New Engl J Med 2011, 365(3):193-195.
• [16]Dutra LM, Glantz SA: Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatr 2014, 168(7):610-617.
• [17]Etter JF, Bullen C: Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011, 106(11):2017-2028.
• [18]Siegel MB, Tanwar KL, Wood KS: Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med 2011, 40(4):472-475.
• [19]Cho JH, Shin E, Moon SS: Electronic-cigarette smoking experience among adolescents. J Adolesc Health 2011, 49(5):542-546.
• [20]King BA, Alam S, Promoff G, Arrazola R, Dube SR: Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res 2013, 15(9):1623-1627.
• [21]Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB: e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health 2012, 102(9):1758-1766.
• [22]Pepper JK, Reiter PL, McRee AL, Cameron LD, Gilkey MB, Brewer NT: Adolescent males’ awareness of and willingness to try electronic cigarettes. J Adolesc Health 2013, 52(2):144-150.
• [23]Sutfin EL, McCoy TP, Morrell HE, Hoeppner BB, Wolfson M: Electronic cigarette use by college students. Drug Alcohol Depend 2013, 131(3):214-221.
• [24]Cressey D: Regulation stacks up for e-cigarettes. Nature 2013, 501(7468):473.
• [25]Borland R: Electronic cigarettes as a method of tobacco control. BMJ 2011, 343:d6269.
• [26]Goniewicz ML, Zielinska-Danch W: Electronic cigarette use among teenagers and young adults in Poland. Pediatrics 2012, 130(4):e879-e885.
• [27]Lee S, Grana RA, Glantz SA: Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attemptsand former smoking. J Adolesc Health 2014, 54(6):684-690.
• [28]Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, Polosa R: EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013, 8(6):e66317.
• [29]Chorti M, Poulianiti K, Jamurtas A, Kostikas K, Tzatzarakis M, Vynias D, Koutedakis Y, Flouris A, Tsatsakis A: Effects of active and passive electronic and tobacco cigarette smoking on lung function. Toxicol Lett 2012, 211(Supplement):S64.
• [30]Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace HA, Tsatsakis AM, Koutedakis Y: Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013, 25(2):91-101.
• [31]Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK: Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012, 141(6):1400-1406.
• [32]Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P: Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012, 34(4):529-537.
• [33]Stanbrook MB: Regulate e-cigarettes as drug-delivery devices. CMAJ 2013, 185(16):1379.
• [34]Office of Information and Regulatory Affairs US Government: “Tobacco Products” Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act. 2013. [cited 01 October 2014]; Available from: http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=201310&RIN=0910-AG38 webcite
• [35]Kuehn BM: FDA: electronic cigarettes may be risky. JAMA 2009, 302(9):937.
• [36]Benowitz NL, Goniewicz ML: The regulatory challenge of electronic cigarettes. JAMA 2013, 310(7):685-686.
• [37]Torjesen I: E-cigarettes are to be regulated as medicines from 2016. BMJ 2013, 346:f3859.
• [38]European Commission: Questions & Answers: New rules for tobacco products. 2014. [cited 01 October 2014]; Available from: http://europa.eu/rapid/press-release_MEMO-14-134_en.htm webcite
• [39]Department of Health Australian Government: Electronic Cigarettes. 2013. [cited 01 October 2014]; Available from: http://www.tga.gov.au/consumers/ecigarettes.htm#UwrVueOSzzh webcite
• [40]Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L: Nicotine levels in electronic cigarettes. Nicotine Tob Res 2013, 15(1):158-166.
• [41]Huang J, Tauras J, Chaloupka FJ: The impact of price and tobacco control policies on the demand for electronic nicotine delivery systems. Tob Control 2014, 23(Suppl 3):iii41-iii47.
• [42]Kostova D, Ross H, Blecher E, Markowitz S: Is youth smoking responsive to cigarette prices? Evidence from low- and middle-income countries. Tob Control 2011, 20(6):419-424.
• [43]Kostova D, Chaloupka FJ, Shang C: A duration analysis of the role of cigarette prices on smoking initiation and cessation in developing countries. Eur J Health Econ 2014. [Epub ahead of print]